Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies
about
Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality AssuranceChemotherapy only in early-stage Hodgkin lymphoma: more relapses but "same" (or possibly worse) survival--reconsidering the misguided trend to omit radiotherapyImproved survival time trends in Hodgkin's lymphomaRisk of second malignancies in patients with early-stage classical Hodgkin's lymphoma treated in a modern era.Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?Second malignant neoplasms following radiotherapy.Risk-adapted strategies for the treatment of Hodgkin lymphoma.Role of Radiation Therapy in the Treatment of Hodgkin Lymphoma.Emerging targets for radioprotection and radiosensitization in radiotherapy.Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis.Adjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study.Second primary malignancies in head and neck cancer patients: high prevalence of curable-stage disease.Clinical outcome of patients with early stage favorable Hodgkin lymphoma treated with ABVD × two cycles followed by FDG-PET/CT restaging and 20 Gy of involved-site radiotherapy.
P2860
Q26766890-90F8D3B0-B534-48E3-BBCD-4C2AF585A6E8Q27015790-4F7DA53F-AB27-4922-BA7D-35C5D7D64F1FQ34676451-DEB2038B-9860-480F-AE83-8B43278BD257Q35469320-E959114E-F465-4F15-AF93-77F4A39F52DDQ36117996-D16B36A6-0C05-4EB5-976C-6004FD5BE73EQ36538754-2B7F8787-F514-4115-9148-5CF17FE61AA9Q38591137-11C32A3B-7B0B-46CA-A642-7D14DD42C04CQ38790112-2729D811-6F39-40F2-A6EE-B02AACBF3BF4Q38869603-5046F6B2-CA82-45F1-BAA2-9BABEAE117C3Q40044179-E9874413-AC12-4D53-B1B9-0818F420538FQ43080580-D85E670F-441D-49C1-B89A-7D94C870B474Q45348241-1B6E3474-D515-40AC-9CF9-4C40777D5FE0Q49932419-3123E1B0-7DF0-46A5-A835-906BDB6B75C3
P2860
Declining use of radiotherapy in stage I and II Hodgkin's disease and its effect on survival and secondary malignancies
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Declining use of radiotherapy ...... val and secondary malignancies
@ast
Declining use of radiotherapy ...... val and secondary malignancies
@en
Declining use of radiotherapy ...... val and secondary malignancies
@nl
type
label
Declining use of radiotherapy ...... val and secondary malignancies
@ast
Declining use of radiotherapy ...... val and secondary malignancies
@en
Declining use of radiotherapy ...... val and secondary malignancies
@nl
prefLabel
Declining use of radiotherapy ...... val and secondary malignancies
@ast
Declining use of radiotherapy ...... val and secondary malignancies
@en
Declining use of radiotherapy ...... val and secondary malignancies
@nl
P2093
P2860
P1476
Declining use of radiotherapy ...... val and secondary malignancies
@en
P2093
Shayna E Rich
Usama Mahmood
Young Kwok
P2860
P304
P356
10.1016/J.IJROBP.2010.10.069
P407
P577
2011-01-27T00:00:00Z